WHO Shaves Anuh APIs Off Prequalification List

In another blow to an Indian drugmaker, the World Health Organization has announced that it is removing two of Anuh Pharma’s products — pyrazinamide and sulfadoxine — from its list of prequalified APIs.

The decision comes after a February inspection by French health officials of the API maker’s Boisar facility that turned up 24 deficiencies. Subsequently, France’s health authority called for the withdrawal of Anuh’s GMP certificate.

WHO said the APIs will remain off its list until the facility’s GMP compliance status has been reinstated.